Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biotech Group Acquisition
New York, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Biotech Group Acquisition Corporation was a special purpose acquisition company (SPAC), also known as a blank check company, formed for the purpose of entering into a merger, share exchange, asset acquisition, or similar business combination. The company intended to focus its search on businesses in the biotechnology and healthcare sectors, particularly those with high growth potential and innovative pipelines. However, after failing to complete a business combination within its required timeframe, the company liquidated and dissolved. It was primarily managed by a team with experience in healthcare investments and capital markets.
- Industry
- Investors
Beyond the preview
Go deeper on Biotech Group Acquisition.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biotech Group Acquisition.